Dr. Reddys Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Quarterly Results    (REDY)

Here are the latest quarterly results of Dr. Reddys. For more details, see the Dr. Reddys financial fact sheet and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Dr. Reddys Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m38,64640,29638,58248,12843,97144,48944,26549,109 
Other income Rs m1,0238334,301540673736871512 
Turnover Rs m39,66941,12942,88348,66844,64445,22545,13649,621 
Expenses Rs m30,60032,10731,16537,49046,85834,99733,05237,548 
Gross profit Rs m8,0468,1897,41710,638-2,8879,49211,21311,561 
Depreciation Rs m2,9032,8722,8903,1312,8692,7412,9233,165 
Interest Rs m241245298303152230233252 
Profit before tax Rs m5,9255,9058,5307,744-5,2357,2578,9288,656 
Tax Rs m1,0111,5081,928-3,207325-4493,0591,011 
Profit after tax Rs m4,9144,3976,60210,951-5,5607,7065,8697,645 
Gross profit margin %20.820.319.222.1-6.621.325.323.5 
Effective tax rate %17.125.522.6-41.4-6.2-6.234.311.7 
Net profit margin %12.710.917.122.8-12.617.313.315.6 
Diluted EPS Rs 29.7 26.5 39.8 66.1 -33.6 46.5 35.4 46.1  
Diluted EPS (TTM) Rs 105.4 115.5 126.6 162.1 98.9 118.9 114.5 94.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Dr. Reddys 3QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   IPCA LABS  GLENMARK PHARMA  BIOCON   NOVARTIS  GSK PHARMA  

Compare DR. REDDYS LAB With:   IPCA LABS  GLENMARK PHARMA  BIOCON   NOVARTIS  GSK PHARMA  

Compare DR. REDDYS LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 136 Points Lower; Telecom and Automobile Stocks Witness Selling(Closing)

Indian share markets witnessed volatile trading activity throughout the day and ended marginally lower.

Views on news

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

PSU Banks Will Move Up Again (Profit Hunter)

Oct 27, 2020

My charts tell me PSU banks are set for a rebound.

PSU Stocks Are Looking Positive Now (Fast Profits Daily)

Oct 19, 2020

Has the market changed its opinion on PSUs?

One Cycle that Defines Everything in Markets (Profit Hunter)

Oct 23, 2020

Know this cycle to boost your profits in the market.

Markets are Always Right? (The Honest Truth)

Oct 30, 2020

Ajit Dayal on why you shouldn't let your guard down as an investor.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Oct 30, 2020 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS